Skip to main content
Watch Insiders
ARTVHealthcare

Artiva Biotherapeutics Inc (ARTV) Insider Trading

In the last 90 days, 4 Artiva Biotherapeutics Inc (ARTV) insiders reported no open-market purchases and 12 sales totaling $1,997,682. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$2,734,354
Corporate buyers
6
Latest transaction
Oct 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 6, 2026Fred AslanChief Executive OfficerSale23,463$7.20$168,880
Oct 5, 2026Christopher HoranChief Tech Operations OfficerSale10,340$6.84$70,697
Oct 5, 2026Jennifer BushCOO, CLO, Compliance OfficerSale8,370$6.84$57,227
Oct 5, 2026Subhashis BanerjeeChief Medical OfficerSale1,099$6.84$7,514
Oct 5, 2026Fred AslanChief Executive OfficerSale61,696$6.84$421,828
Sep 8, 2026Fred AslanChief Executive OfficerSale23,429$10.92$255,746
Sep 3, 2026Christopher HoranChief Tech Operations OfficerSale10,366$11.16$115,638
Sep 3, 2026Jennifer BushCOO, CLO, Compliance OfficerSale8,391$11.16$93,606
Sep 3, 2026Subhashis BanerjeeChief Medical OfficerSale1,100$11.16$12,271
Sep 3, 2026Fred AslanChief Executive OfficerSale61,888$11.16$690,392
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

ARTV insider trading FAQ

Are ARTV insiders buying or selling?
Over the last 90 days, ARTV insiders were net sellers, reporting $0.00 of open-market purchases and $1,997,682 of sales.
When was the last ARTV insider purchase?
No open-market insider purchase of Artiva Biotherapeutics Inc stock was reported in the last 90 days.
Where does ARTV insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Artiva Biotherapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.